Pharmafile Logo
Pharmafocus logo
Advanced Search

diabetes

Showing 15 posts of 391 posts found.

Sanofi glucose monitor

Sanofi launches iPhone and iPod glucose monitor in the UK

March 12, 2012
Medical Communications, Sales and Marketing BGStar, Sanofi, diabetes, iPod, iphone

Sanofi has launched a new diabetes device in the UK to help patients monitor their blood sugar levels from their …

News
Novo Nordisk image

Diabetes – the battle for control

February 15, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Novo Nordisk, Sanofi, Victoza, degludec, diabetes

This year marks the 90th anniversary of the first ever successful use of insulin to treat patients with type I …

Feature

AZ and BMS diabetes drug needs more data

January 20, 2012
Research and Development, Sales and Marketing AstraZeneca, BMS, FDA approvals, diabetes

AstraZeneca and Bristol-Myers Squibb must supply more data on their diabetes treatment dapagliflozin, the FDA says.Currently being developed as monotherapy, …

News
Sanofi picture

Sanofi to collaborate with UCSF on diabetes research

January 11, 2012
Research and Development RNA interference, Sanofi, UCSF, academic alliance, diabetes

The University of California, San Francisco (UCSF) and Sanofi are to launch a new collaboration in diabetes research, focusing on …

News

Study supports GLP-1 agonists for weight loss

January 10, 2012
Research and Development, Sales and Marketing GLP-1, Novo Nordisk, Sanofi, diabetes, lilly

An independent study by academics has concluded that GLP-1 agonist drugs help patients to lose weight – with the effect …

News

AstraZeneca takes option on new diabetes candidates

December 21, 2011
Sales and Marketing AstraZeneca, diabetes

AstraZeneca and Prosidion, a subsidiary of Astellas have signed a deal giving AstraZeneca an exclusive option to acquire two diabetes …

News

Novo confident on ultra-long acting insulin

December 8, 2011
Sales and Marketing Novo Nordisk, diabetes, insulin

Novo Nordisk says a new combination of a long-acting insulin with a short-acting insulin helps patients maintain better control of …

News

No cancer link with Lantus, says Sanofi

December 7, 2011
Sales and Marketing Cancer, Lantus, Sanofi, diabetes, insulin, safety

Sanofi has presented a new meta-analysis which suggests its insulin blockbuster Lantus does not raise the risk of cancer. A …

News

Onglyza cleared for use with insulin

November 29, 2011
Sales and Marketing AstraZeneca, Merck, Onglyza, diabetes, insulin

European regulators have approved a licence extension for Bristol-Myers Squibb and AstraZeneca’s type II diabetes treatment Onglyza. The oral DPP-4 …

News

GSK diabetes drug fails head-to-head against Victoza

November 16, 2011
Sales and Marketing GLP-1, Victoza, albiglutide, diabetes

GlaxoSmithKline’s long-acting diabetes drug albiglutide has failed in a head-to-head trial against Novo Nordisk’s Victoza. Albiglutide is an injectable glucagon-like …

News

Byetta approved for use with insulin

October 19, 2011
Amylin, GLP-1, diabetes, lilly

The FDA has approved the use of Lilly and Amylin’s diabetes treatment Byetta as an add-on therapy to insulin glargine.The …

News
Byetta

NICE recommends Lilly’s long-acting Bydureon

October 18, 2011
Sales and Marketing Bydureon, NICE, diabetes

NICE has recommended Eli Lilly’s long-acting diabetes drug Bydureon after the failure of oral treatments. Bydureon (exenatide) – a long-acting …

News

Russian diabetes market to grow to $1.7 billion

October 17, 2011
Sales and Marketing Russia, diabetes

Russia’s diabetes market is set be worth $1.7 billion by 2015, according to a new report. Industry analysts Decision Resources’ …

News
Victoza

Novo Nordisk’s Victoza launched in China

October 10, 2011
Sales and Marketing Byetta, China, Victoza, diabetes

Novo Nordisk’s Victoza is now available in China, one of the fastest growing diabetes markets in the world. Victoza (liraglutide …

News

NHS ‘wasted’ £625 million on modern insulin

September 23, 2011
Sales and Marketing diabetes, insulin

The NHS has wasted £625 million on modern insulin products over the last decade, according to a new report in …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026